24 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... Agent, Initiation Dose ... #Neuropathic #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... and Management Initiative ... #Management # ... Pain #Pharmacology ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Management # ... Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Procedural Sedation and Analgesia Medications 

#Management #Pain #Pharmacology #PSA
Pain Assessment ... and Management Initiative ... #Management ... #Pain #Pharmacology ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... #Management # ... Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Stress Dose Steroids - Indications and Dosing

SUPPRESSED HPA AXIS:
 prednisone >20mg/day x 3 weeks or more
Stress Dose Steroids ... - Indications and ... Dosing SUPPRESSED ... #Dosing #Endocrinology ... #Diagnosis #Management
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... very tolerable medication ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... and Management Initiative ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... #diabetes #medications ... #table #comparison ... #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Adjust insulin dose ... Diabetes #Mellitus #DM2 ... #pharmacology #comparison ... #table #endocrinology